Cancer staging is the process of gathering information to determine the location and extent of a cancer diagnosis. For patients diagnosed with non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC), tests are performed to determine if the cancer has spread within the chest or to distant areas of the body.
As part of the staging process, biomarker testing may also be conducted for NSCLC to identify specific gene mutations, such as EGFR, ALK, KRAS, and TP53. These biomarkers can also help guide treatment decisions.
This information helps lung cancer doctors understand the seriousness of the disease, recommend a treatment plan, identify potential clinical trials for viable treatment options, and even provide chances of survival.
Additional tests and procedures that may be used in the small cell lung cancer staging process include:
In limited-stage small cell lung cancer, cancer is found in one lung, the tissues between the lungs, and nearby lymph nodes only.
In extensive-stage small cell lung cancer, cancer has spread outside of the lung in which it began or to other parts of the body.
Additional tests and procedures that may be used in the non-small cell lung cancer staging process include:
In this stage, cancer cells are found in sputum (mucus coughed up from the lungs), but no tumor can be found in the lung by imaging or bronchoscopy, or the primary tumor is too small to be checked.
In stage 0, abnormal cells are found in the innermost lining of the airways. These abnormal cells may become cancer and spread into nearby normal tissue. Stage 0 is also called carcinoma in situ (localized).
Cancer has formed. Stage I is divided into stages IA and IB:
Stage II is divided into stages IIA and IIB:
Stage III is divided into stages IIIA, IIIB, IIIC:
Stage IV is divided into stages IVA and IVB.
Despite advancements in lung cancer treatment, there is still a chance of lung cancer returning after remission. The likelihood of recurrence depends on the type of lung cancer and initial stage at the time of treatment. If lung cancer returns, it is classified based on its location: local recurrence (cancer reappears in the original lung), regional recurrence (cancer spreads to nearby lymph nodes or tissues), and distant recurrence (cancer spreads to other parts of the body).
If you or a loved one have been newly diagnosed with lung cancer, our oncologists specialize in lung cancer and are ready to guide you through this journey. For patients in the Portland, OR, and Vancouver, WA areas, we offer the latest lung cancer treatment options tailored to you.
Request an appointment with one of our oncologists to discuss a lung cancer diagnosis including the extent of your cancer, biomarker testing, and a personalized lung cancer treatment plan.